DBV is a biotechnology company committed to helping children with food allergies live safely. We are developing Viaskin , a non-invasive patch technology based on epicutaneous immunotherapy, that re-educates the immune system through the skin. Our goal is to offer families a safe, effective, and accessible treatment option to help protect them from accidental exposure reactions.